Upgrade to SI Premium - Free Trial

Credit Suisse Upgrades Biogen (BIIB) to Outperform, After FDA Related Business Update

August 7, 2020 2:57 PM
Credit Suisse analyst Evan Seigerman upgraded Biogen (NASDAQ: BIIB) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Upgrades